The Effects of Journaling on Health-Related Mood and Clinical Outcomes in Post-MI Patients

Last updated: October 7, 2019
Sponsor: University of California, San Diego
Overall Status: Completed

Phase

N/A

Condition

Hypercholesterolemia

Blood Clots

Cardiac Disease

Treatment

N/A

Clinical Study ID

NCT02481544
1R21AT008033-01A1
  • Ages > 35
  • All Genders

Study Summary

Psychosocial factors, including positive affect, finding meaning in the event, and managing emotional distress, influence prognosis following a heart attack or myocardial infarction (MI). Gratitude, typically defined as a feeling or attitude in acknowledgment of a benefit that one has received or will receive, is associated with higher levels of well-being, and people who are more grateful experience less stress, are less depressed, have higher levels of control over their environment, and more positive ways of coping. The present project will examine the potential benefits of a gratitude intervention (i.e., 8 weeks of gratitude journaling) to increase positive health behaviors, psychological health, and physical functioning in post-MI patients as compared to journaling about memorable events as well as care as usual alone. The investigators will study psychological and physical functioning at baseline, following 8 weeks of gratitude journaling or care as usual, and at 4-month follow-up.

Eligibility Criteria

Inclusion

Inclusion criteria:

  1. Suffered an MI (ST Elevation MI (STEMI) or Non-ST Elevation MI (NSTEMI) with creatinekinase MB fraction elevation 3 times the upper limits of normal and with ischemic ECGchanges within 12 months of baseline testing;

  2. An EF less than 50% on echocardiogram;

  3. Clinically stable defined as, no active arrhythmia, no residual ischemia;

  4. Able to perform light to moderate exercise;

  5. Able to give informed consent in English;

  6. Medical clearance by their cardiologist;

  7. > 35 years of age.

Exclusion

Exclusion criteria:

  1. Unstable angina;

  2. Severe valvular disease;

  3. Oxygen-dependent COPD;

  4. Recent stroke or significant cerebral neurologic impairment;

  5. Suicidality with intent or plan;

  6. Current cancer;

  7. Currently taking mood stabilizers, benzodiazepines or antipsychotics;

  8. Medications (e.g., systemic steroids) and conditions affecting immune status (e.g.,rheumatoid arthritis, hepatitis C, HIV) (Anti-depressant medication is allowed);

  9. Currently enrolled in another clinical trial.

Study Design

Total Participants: 108
Study Start date:
April 01, 2015
Estimated Completion Date:
January 31, 2019

Connect with a study center

  • University of California, San Diego

    La Jolla, California 92093
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.